Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
UNHUnitedHealth Group
FinDog View：Neutral
| Metric | ABT | UNH |
|---|
| Close | 102.36 | 375.26 |
| Market Cap | $177B | $337B |
| 1M | −7.26% | −5.15% |
| P/E (TTM) | 33.2 | 23.9 |
| Forward P/E | 18.1 | 19.7 |
| P/E 5-Yr Percentile | 66 | 53 |
| P/S | 3.9 | 0.8 |
| P/B | 3.5 | 3.2 |
| Dividend Yield | 1.98% | 1.37% |
| Latest Quarter Revenue | $11.2B | $112B |
| Revenue YoY | +7.8% | +0.4% |
| Gross Margin | 56.2% | 88.1% |
| Latest Quarter EPS | 0.61 | 6.04 |
| Avg Post-Earnings Move | ±1.6% | ±3.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.81% | 2.89% |
| 90-Day Net Insider Buying | −$46.7M | −$0.66M |
ABT · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
